DISUBSTITUTED PHENYLPYRROLIDINES AS MODULATORS OF CORTICAL CATECHOLAMINERGIC NEUROTRANSMISSION
申请人:Sonesson Clas
公开号:US20100197760A1
公开(公告)日:2010-08-05
The present invention provides compounds which increase extracellular levels of catecholamines, dopamine and norepinephrine, in cerebral cortical areas of the mammalian brain, and more specifically to the use of 3-(disubstituted aryl)-pyrrolidines for the treatment of central nervous system disorders.
本发明提供了一种能够增加哺乳动物大脑皮层区域多巴胺和去甲肾上腺素等儿茶酚胺类物质的细胞外水平的化合物,更具体地,本发明提供了使用3-(二取代芳基)-吡咯烷类化合物治疗中枢神经系统疾病的方法。